Yin XX[Author] - Search Results

Year	Number of Results
1991	1
1997	2
2003	1
2004	1
2005	2
2006	3
2007	4
2008	2
2009	1
2010	1
2011	12
2012	12
2013	11
2014	8
2015	14
2016	8
2017	16
2018	9
2019	9
2020	8
2021	23
2022	17
2023	5
2024	2

1

Dietary nutrition for neurological disease therapy: Current status and future directions.

Mao XY, Yin XX, Guan QW, Xia QX, Yang N, Zhou HH, Liu ZQ, Jin WL. Mao XY, et al. Among authors: yin xx. Pharmacol Ther. 2021 Oct;226:107861. doi: 10.1016/j.pharmthera.2021.107861. Epub 2021 Apr 23. Pharmacol Ther. 2021. PMID: 33901506 Review.

2

U-Net-Based Medical Image Segmentation.

Yin XX, Sun L, Fu Y, Lu R, Zhang Y. Yin XX, et al. J Healthc Eng. 2022 Apr 15;2022:4189781. doi: 10.1155/2022/4189781. eCollection 2022. J Healthc Eng. 2022. PMID: 35463660 Free PMC article. Retracted. Review.

3

The mutual interplay of redox signaling and connexins.

Zhang K, Guan QW, Zhou XY, Xia QX, Yin XX, Zhou HH, Mao XY. Zhang K, et al. Among authors: yin xx. J Mol Med (Berl). 2021 Jul;99(7):933-941. doi: 10.1007/s00109-021-02084-0. Epub 2021 Apr 29. J Mol Med (Berl). 2021. PMID: 33928434 Review.

4

Digital Filtering Techniques Using Fuzzy-Rules Based Logic Control.

Yin XX, Hadjiloucas S. Yin XX, et al. J Imaging. 2023 Sep 30;9(10):208. doi: 10.3390/jimaging9100208. J Imaging. 2023. PMID: 37888315 Free PMC article. Review.

5

Resveratrol prevents Drp1-mediated mitochondrial fission in the diabetic kidney through the PDE4D/PKA pathway.

Zhu X, Deng Z, Cao Y, Zhou Z, Sun W, Liu C, Fan S, Yin XX. Zhu X, et al. Among authors: yin xx. Phytother Res. 2023 Dec;37(12):5916-5931. doi: 10.1002/ptr.8004. Epub 2023 Sep 28. Phytother Res. 2023. PMID: 37767771

6

MRI Radiogenomics in Precision Oncology: New Diagnosis and Treatment Method.

Yin XX, Gao M, Wang W, Zhang Y. Yin XX, et al. Comput Intell Neurosci. 2022 Jul 7;2022:2703350. doi: 10.1155/2022/2703350. eCollection 2022. Comput Intell Neurosci. 2022. PMID: 35845886 Free PMC article. Review.

7

Antioxidants Targeting Mitochondrial Oxidative Stress: Promising Neuroprotectants for Epilepsy.

Yang N, Guan QW, Chen FH, Xia QX, Yin XX, Zhou HH, Mao XY. Yang N, et al. Among authors: yin xx. Oxid Med Cell Longev. 2020 Nov 25;2020:6687185. doi: 10.1155/2020/6687185. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 33299529 Free PMC article. Review.

8

HILIC-MS for metabolomics: An attractive and complementary approach to RPLC-MS.

Tang DQ, Zou L, Yin XX, Ong CN. Tang DQ, et al. Among authors: yin xx. Mass Spectrom Rev. 2016 Sep;35(5):574-600. doi: 10.1002/mas.21445. Epub 2014 Oct 3. Mass Spectrom Rev. 2016. PMID: 25284160 Review.

9

Lysyl oxidases: Emerging biomarkers and therapeutic targets for various diseases.

Yang N, Cao DF, Yin XX, Zhou HH, Mao XY. Yang N, et al. Among authors: yin xx. Biomed Pharmacother. 2020 Nov;131:110791. doi: 10.1016/j.biopha.2020.110791. Epub 2020 Sep 23. Biomed Pharmacother. 2020. PMID: 33152948 Free article. Review.

10

Molecular hydrogen: a preventive and therapeutic medical gas for various diseases.

Ge L, Yang M, Yang NN, Yin XX, Song WG. Ge L, et al. Among authors: yin xx. Oncotarget. 2017 Sep 21;8(60):102653-102673. doi: 10.18632/oncotarget.21130. eCollection 2017 Nov 24. Oncotarget. 2017. PMID: 29254278 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

146 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Results by year